Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/ix-biopharma-signs-exclusive-license-agreement-for-wafermine-and-other-sublingual-ketamine-wafer-products-301432286.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-acquisition-of-an-exclusive-license-of-ix-biopharmas-proprietary-wafer-based-delivery-platform-for-sublingual-ketamine-301431260.html
https://www.prnewswire.com/news-releases/ix-biopharmas-xativatm-bags-cbd-product-of-the-year-accolade-from-the-australian-cannabis-industry-awards-2020-301187990.html
https://www.prnewswire.com/news-releases/ix-biopharma-receives-positive-ema-scientific-advice-for-waferminetm-301187988.html#:~:text=SINGAPORE%2C%20Dec.%208%2C%202020,its%20Phase%203%20clinical%20development